Seeking Alpha

Supernus Pharmaceuticals (SUPN): Q4 EPS of -$0.51 beats by $0.20. Revenue of $1.09M. (PR)

Supernus Pharmaceuticals (SUPN): Q4 EPS of -$0.51 beats by $0.20. Revenue of $1.09M. (PR)
Comments (1)
  • saltara22
    , contributor
    Comments (2) | Send Message
     
    SUPN is a steal at this price....I see a target price of 10
    15 Mar 2013, 05:28 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs